A Case of a Secretory Carcinoma of the Breast: Radio-Pathological Correlation by Shinya Tajima et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






A Case of a Secretory Carcinoma of the Breast: 
Radio-Pathological Correlation 
Shinya Tajima1, Ichiro Maeda2, Yasuyuki Kurihara1, Miyuki Fukushima2, 
Yoshihide Kanemaki1, Hiroshi Shimamoto1, Keiko Kishimoto1,  
Tomoko Uejima3, Koichiro Tsugawa3 and Yasuo Nakajima1 
1Department of Radiology,  
2Department of Pathology,  
3Department of Breast Surgery,  
St. Marianna University School of Medicine, Kanagawa,  
Japan 
1. Introduction 
Secretory carcinoma of the breast is a rare variant (the frequency is below 0.15 %) of breast 
tumor1, 2. It was first described by McDivitt and Stewart in 1966, as a juvenile breast 
carcinoma as it was thought to occur only in childhood3. Subsequently, in 1970 Norris et al.2 
and in 1980 Tavassoli et al.4 advocated “secretory carcinoma” based on histopathological 
feature. It is now well known to occur in all age groups. As review of available literature, 
about 100 cases of secretory carcinoma of the breast has been reported at histopathology5. 
However, its gene expression profiling and the imaging appearances of this carcinoma are 
not well described. We report the gene expression profiling and the imaging characteristics 
of the secretory carcinoma of the breast. 
2. Case report 
The patient had no palpable mass or nipple discharge or axillary lymph node swelling but 
she was pointed out abnormality in her left breast for the screening of mammography and 
ultrasonography. She visited our hospital for further examination and medical treatment. 
Mammography showed multiple iso-density masses with unclear and partly spiculated 
margin on the mid portion of left Mediolateral-oblique view and inner portion of left 
Cranio-caudal view (Figure1A, 1B). Ultrasonography revealed multiple nodular hypo-
echoic masses measured 67 × 14 mm with high Depth/Width ratio, which suggested a 
malignant nature (Figure 2). Then HR-MRI on a 1.5-T system using a surface breast coil was 
performed. Diffusion weighted HR-MR image showed multiple mass-like high signal 
intensities. Contrast enhanced T1 weighted HR-MR image of early phase showed segmental 
distribution of multiple nodular mass-like enhancements measured by 60 × 40 mm (Figure 
3A, 3B). Thus malignancy was suspected. Non-contrast enhanced T1 weighted image of HR-
MRI revealed multiple dot-like high signal intensities in the mass (Figure 3C). Therefore this 
tumor was thought to contain rich protein or hemorrhage. Fat-saturated T2 weighted image 
of HR-MRI revealed nodular high signal intensities in the mass (Figure 3D). 
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Fig. 1. A. MLO view of mammography, B: CC view of mammography; Multiple iso-density 
masses with unclear and partly spiculated margin are seen on the mid portion of left MLO 
view (A) and inner portion of left CCview (B). 
 
Fig. 2. Ultrasonography of the left breast; Multiple nodular hypo-echoic masses with high 
Depth/Width ratio are seen and which suggested a malignant nature. 
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Fig. 3A. Diffusion weighted image of HR-MRI; Multiple mass-like high signal intensities are 






Fig. 3B. Contrast enhanced T1 weighted image on early phase of HR-MRI; Segmental 
distribution of multiple nodular mass-like enhancements are seen in the left breast. These 
mass-like enhancements might reflect the nodular growth of the secretory carcinoma. 
www.intechopen.com




Fig. 3C. Non-contrast enhanced T1 weighted image of HR-MRI; Multiple dot-like high 
signal intensities are seen on the mass (arrows). These high signal intensities might reflect 
the secretory material of the secretory carcinoma. 
 
Fig. 3D. Fat-saturated T2 weighted image of HR-MRI; Multiple nodular high signal 
intensities are seen on the mass (arrows). These high signal intensities might reflect the 
secretory material of the secretory carcinoma. 
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Cytology showed typical aggregated forms of tumor cells like bunches of grapes and the 
cytologic smears revealed grapelike clusters of mucous globular structures (MGSs) and 
speculated as a secretory carcinoma (Figure 4). Then left mastectomy was performed as a 
curative operation. Grossly, the tumor measured 6.8 × 4.5 × 2.0 cm and was gray-whitish 
circumscribed multiple nodular firm mass. And the tumor size was concordant with HR-MR 
imaging findings. The resected specimen of histopathological feature was microcystic or 
glandular architecture and composed of cells that produce abundant intracellular and 
extracellular secretory material, and immunohistochemically the tumor was positive for 
periodic acid-Schiff (PAS) as well as S-100 protein. The tumor consisted cells of pale-to-clear 
or eosinophilic cytoplasm, and small, round, low-grade nuclei with inconspicuous nucleoli. 
The tumor cells showed nodular growth and invasion of the adipose tissue was seen part of 
the tumor. Hence that was diagnosed a secretory carcinoma (Figure 5A, 5B, 5C, 5D). 
Secretory carcinoma is associated with a genetic ETV-6-NTRK3 gene fusion leading to a 
chimeric protein tyrosinase kinase expression, however it was not experimented in the 
present case. 
ER, PgR, and HER2 were all negative and triple negative cancer is suggested in our case. 
Immunohistochemically, the tumor cells are CK5/6, CK8/18, EGFR, vimentin, and c-kit all 
positive and our case of secretory carcinoma was considered to have the spectrum of basal-
like type in gene expression profiling. 
 
Fig. 4. Cytology of the secretory carcinoma (Papanicolaou stain, ×400); Aggregated forms of 
tumor cells like “bunches of grapes” are seen. 
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Fig. 5. A: Histology of the secretory carcinoma (Haematoxylin and Eosin stain, ×2); Low 
magnification view of the secretory carcinoma. The secretory carcinoma of the nodular 
growth is seen. B: Histology of the secretory carcinoma (Periodic acid-Schiff stain, ×200); 
Higher magnification view of the secretory carcinoma. The secretory material of the 
secretory carcinoma is positive for Periodic acid-Schiff stain. C, D: Histology of the secretory 
carcinoma (Figure 5C; Haematoxylin and Eosin stain ×100, Figure 5D; Haematoxylin and 
Eosin stain, ×400); Higher and high magnification view of the secretory carcinoma. The 
carcinoma cells arranged microcystic or glandular architecture and abundant intracellular 
and extracellular secretory material is seen. 
3. Discussion 
Secretory carcinoma of the breast is a rare but histopathologically distinct variant of invasive 
ductal carcinoma that thought to be indolent growth pattern and a more favorable prognosis 
than that of typical ductal carcinoma6. The frequency is thought to be below 0.15 % of all 
breast tumors1, 2. In our hospital, the frequency was 0.05 %. 
By using DNA microarray techniques, it has been shown that breast cancers can be classified 
into biologically distinct groups based on their gene expression profiles. These groups 
comprise luminal A (ER positive and HER2 negative), luminal B (ER and HER2 positive), 
ERBB2 (ER negative and HER2 positive), and triple negative (ER and HER2 negative) 
subtypes7. Our case was ER, PgR and HER2 negative, hence the triple negative cancer is 
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suggested. The triple negative cancer is a heterogeneous group and is further categorized 
into the basal-like and the normal breast subtypes, which are positive and negative, 
respectively, for myoepithelial/basal markers such as basal CKs. The consensus criteria for 
the basal-like subtype which has been reported is as follows. Nielsen et al. suggested four 
representative surrogate markers for the basal-like subtype: ER, HER2, EGFR, and CK5/68. 
Other additional criteria used for the basal-like subtype comprise (1) ER negativity and 
HER2 negativity, and vimentin, EGFR, CK8/18, and/or CK5/6 positivity, and (2) triple 
negativity, and CK5/6 and/or EGFR positivity7. Other markers that have been included in 
the myoepithelial/basal biomarkers are laminin9, 10, c-kit11, p6312, nestin13, osteonectin14, 
caveolin 115. In the present case, the tumor cells were CK5/6, CK8/18, EGFR, vimentin, and 
c-kit all positive and our case of secretory carcinoma was considered to have the spectrum of 
basal-like type in gene expression profiling. Lae et al reported that secretory carcinomas in 
woman were ER negative, PgR negative and HER2 negative, so called triple negative16. The 
tumors were also reactive for S100 and E-cadherin and focally for CK8/18 and CK5/616. Our 
case was compatible with the report of Lae et al.. Secretory carcinoma has been reported as 
low-grade carcinoma, however our case suggests that not always a secretory carcinoma is 
low-grade carcinoma. Triple negative cancer is considered to be a clinicopathological entity 
with aggressive behaviors and poor prognosis. Our case suggests that the secretory 
carcinoma of the breast should need careful therapeutic follow up. 
Here we will discuss about the imaging features of the secretory carcinoma. Mammography 
of a secretory carcinoma usually reveals a discrete tumor with smooth or irregular borders17. 
Also, our case of mammography showed multiple iso-density masses with unclear and 
partly spiculated margin and this finding was not specific for the entity of a secretory 
carcinoma. On ultrasonography, secretory carcinoma of the breast is frequently shown as a 
small benign-looking nodule or group of nodules with low clinical stage18. And secretory 
carcinoma of ultrasonographic appearance is a solid, well-circumscribed mass and is not 
specific for this entity and mimics benign entities such as fibroadenoma, as well as other 
well-differentiated breast carcinomas19. Ultrasonography of the present case revealed 
multiple nodular hypo-echoic masses measured 67 × 14 mm with high Depth/Width ratio, 
which suggested a malignant nature, however was not specific for a secretory carcinoma. It 
is not well known that the HR-MR imaging feature of secretory carcinoma of the breast. 
However, in our case, dot-like high signal intensities within the mass were observed on T1 
and high signal intensities on T2 weighted images on HR-MRI and additionally nodular 
multiple mass-like early enhancements were seen on contrast enhanced HR-MR imaging. 
Therefore this tumor was thought to contain rich protein or hemorrhage. The rich protein 
lesions reveal high signal intensity not only T1 weighted image but also T2 weighted image 
on HR-MR imaging by the concentration of protein20, 21, 22. Dot-like high signal intensities on 
T1 weighted image and nodular high signal intensities on fat-saturated T2 weighted image 
of HR-MRI might correspond to the groups of intracellular and extracellular secretory milk-
like material of the secretory carcinoma (Figure 3C, 3D, 5C, 5D). And mass-like early 
enhancements on contrast enhanced T1 weighted HR-MR image might correspond to the 
nodular growth of the secretory carcinoma (Figure 3B, 5A). Moreover, these findings of dot-
like high signal intensities on T1 weighted image with the distribution of scattered within 
the mass and high signal intensities on T2 weighted image of HR-MRI besides mass-like 
early enhancement on contrast enhanced T1 weighted HR-MR images are thought to be one 
of the imaging features of secretory carcinoma of the breast. Differential diagnoses of the 
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secretory carcinoma on imaging characteristics including HR-MRI might theoretically be 
mucinous carcinoma of pure and mixed forms, sarcomas (angiosarcoma, myxofibrosarcoma 
and so on ), and matrix-producing carcinoma as concerning about mucinous or rich protein 
lesion, and invasive ductal carcinoma with hemorrhage and angiosarcoma as concerning 
about hemorrhage on HR-MR images. Mucinous carcinoma of pure and mixed forms might 
typically reveal lobulated shape and very high signal intensity on T2 weighted images, and 
a pattern of gradual enhancement or heterogenous enhancement on dynamic HR-MR 
images23. And the most common appearance of mucinous carcinoma is a hypo-echoic lesion 
with heterogenous internal echo on ultrasonography24. Matrix-producing carcinoma might 
typically reveal hypo- or high-echoic zone in the tumor on ultrasonography and ring-
shaped enhancement on contrast enhanced HR-MRI with high signal intensity in the central 
area of the tumor on T2 weighted imaging25. Angiosarcoma might typically reveal both a 
high- and hypo-echoic lesion without acoustic shadow on ultrasonography26, and HR-MRI 
of angiosarcoma might reveal low intensity tumor on T1 weighted images, markedly high 
intensity on T2 weighted images and prolongation of enhancement on the dynamic study 
and the presence of multiple regions without enhancement in the tumor27. Sarcomas might 
contain mucinous lesion, however the distribution of mucin might not be typically dot-like 
and scattered in the mass on T1 weighted image of HR-MRI. Invasive ductal carcinoma with 
hemorrhage and angiosarcoma might have hemorrhagic lesion and sometimes reveal high 
signal intensity on T1 weighted image of HR-MRI, however their distribution might rarely 
be scattered in the mass on T1 weighted image of HR-MRI.  
In conclusion, these findings of dot-like high signal intensities on T1 weighted image with 
their distribution of scattered within the mass and high signal intensities on T2 weighted 
image of HR-MRI besides mass-like early enhancement on the dynamic HR-MR image are 
thought to be one of the imaging features of secretory carcinoma of the breast. And our 
findings of HR-MR images might be helpful to diagnose the secretory carcinoma of the 
breast on HR-MR imaging. 
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